Cervical Carcinoma — Trials

Cervical Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

504 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 170
Recruiting: 81
Ph III recruiting: 11
Growth YoY: +3.3%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (54)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03987555	Paclitaxel Therapeutic Drug Monitoring in Cancer Patients	suspended	—	55	Wake Forest University Health SciencesOTHER	1	Aug 13, 2026	clinicaltrials
NCT05337735	A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers	suspended	Phase 2	140	M.D. Anderson Cancer CenterOTHER	1	May 4, 2026	clinicaltrials